Jim Green­wood set to de­part from BIO af­ter US elec­tions — vows to en­sure law­mak­ers don't 'kill in­no­va­tion'

The her­culean US drug lob­by is los­ing one of its flag­bear­ers: BIO CEO Jim Green­wood.

For more than 14 years Green­wood has led BIO, which has tripled in size un­der his reign and re­brand­ed it­self as the Biotech­nol­o­gy In­no­va­tion (pre­vi­ous­ly In­dus­try) Or­ga­ni­za­tion. He is set to de­part af­ter the US elec­tions next year, and will help tran­si­tion a new leader to rep­re­sent the biotech in­dus­try and “de­fend in­no­va­tion from do­mes­tic po­lit­i­cal at­tacks.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER